• Ascendis Pharma EPS for the quarter ending September 30, 2024 was $-1.89, a 39.68% decline year-over-year.
• Ascendis Pharma 2023 annual EPS was $-9.25, a 15.54% decline from 2022.
• Ascendis Pharma 2022 annual EPS was $-10.96, a 32.3% increase from 2021.
• Ascendis Pharma 2021 annual EPS was $-8.28, a 12.43% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.